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Abstract: Early screening of individuals considered to be at risk for severe internal carotid artery (ICA) stenosis is an 
important strategy for preventing ischemic cerebral stroke. The purpose of this study is to screening candidate single 
nucleotide polymorphisms (SNPs) associated with severe ICA stenosis using a newly developed oligonucleotide-based 
custom DNA array. The subjects consisted of 47 controls and 46 patients with severe ICA stenosis ( 70%) who underwent 
carotid endarterectomy (CEA). Subjects gave informed consent and we obtained samples of blood and genomic DNA. We 
studied 8 candidate genes: renin-angiotensin system [angiotensinogen (AGT), angiotensin II receptor type 1 (AGTR1), 
nitric oxide synthase 3 (NOS3)]; growth factor [hepatocyte growth factor (HGF)]; transgelin (SM22); cytokine [chemokine 
receptor 2 (CCR2)]; coagulation-ﬁ  brinolysis system [5,10-methylenetetrahydrofolate reductase (MTHFR)]; and plasmino-
gen activator inhibitor 1 (PAI-1). Genotyping of candidate SNPs was done with a line probe assay (LiPA) based on an 
oligonucleotide-based DNA array. Results: The allele frequency of PAI-1 –1965 delG (odds ratio (OR), 0.3; 95% conﬁ  dence 
interval (CI), 0.2–0.6) and MTHFR (OR 1.3, 95% CI, 1.0–1.5) were signiﬁ  cantly different between controls and cases with 
ICA stenosis by Fisher’s exact test. Multiple logistic analysis revealed that diabetes mellitus (DM), SNPs in PAI-1 –1965 
delG and MTHFR were an independent risk for ICA stenosis. In conclusion, genetic factors of coagulation-ﬁ  brinolysis as 
well as diabetes mellitus (DM) were relevant in ICA stenosis.
Keywords: atherosclerosis, carotid artery stenosis, polymorphism, plasminogen activator inhibitor 1; 5,10-methylenetetra 
hydrofolate reductase
Introduction
Early screening of individuals at risk for severe internal carotid artery (ICA) stenosis is an important 
strategy for preventing carotid-related stroke. Given the current knowledge of DNA sequences, single 
nucleotide polymorphisms (SNPs) are likely to represent valuable resources. The risk of ICA stenosis 
may be inﬂ  uenced partly by a coupled pattern of inheritance. However, the standardization of genotyp-
ing of SNPs has not been fully established.
Two different strategies for the post-sequencing phase of the Human Genome Project have been 
proposed (Collins and Guyer, 1997). One plan involves the systematic identiﬁ  cation of all common 
variations in human genes. The second strategy involves the use of very dense maps of single nucleotide 
polymorphisms (SNPs). At this stage of the post-sequence era, SNPs are likely to represent valuable 
therapeutic targets for medical research, since they may be associated with susceptibility to disease or 
pharmacological responsiveness (Collins and Guyer, 1997; Kruglyak, 1997). Thus, SNPs may play a 
role in many common diseases, and may well underlie the need for individualized patient therapy 
(Lander, 1996). Hence, a systematic method for cataloging human SNPs was proposed (Livak et al. 
1995), and several surveys of this type have been reported (Cargill et al. 1999; Halushka et al. 1999; 
Ohnishi et al. 2000). Highly multiplexed genotyping methods are needed to support a comprehensive 
analysis of SNP-related genes in ICA stenosis. The purpose of this study is screening SNPs markers 
that associated ICA stenosis by oligonucleotide-based custom DNA array.64
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Subjects and Methods
We studied 47 control individuals without ICA 
stenosis and 46 consecutive patients with severe 
ICA stenosis ( 70%) who underwent carotid 
endarterectomy (CEA). While 27 patients evinced 
ipsilateral carotid territory symptoms, 19 patients 
exhibited asymptomatic ICA stenosis. The 
assessments of the risk factors as well as the 
personal history of vascular events were collected 
at enrolment. The risk factors assessed were: 
hyperlipidemia (total cholesterol  220 mg/dL, 
triglyceride  150 mg/dL, HDL-cholesterol  40 
mg/dL), hypertension (systolic and/or diastolic 
pressure  160/90 mm/Hg on more measurements), 
diabetes mellitus (HbA1c  6%), and overweight 
(BMI   26). Carotid arteries were studied by 
ultrasound sonography to determine the type of 
plaque, internal media thickness (IMT), and degree 
of stenosis of plaques.
Ultrasound Assessment 
of the Carotid Arteries
The ultrasound assessment of the extra-cranial 
carotid arteries was performed using a color 
doppler ultrasound sonograph instrument (GE 
Yokogawa, LOGIQ 500, Japan) equipped with an 
11-MHz multifocal linear-array transducer. The 
scanning protocol entails the longitudinal scan-
ning of the near and far wall of both carotid 
arteries at the distal common carotid artery, 
carotid bifurcation, and proximal internal carotid 
artery. The common carotid artery was deﬁ  ned as 
the portion 10 mm below the dilatation of the 
bulb; the bifurcation was deﬁ  ned proximally by 
this landmark; the internal carotid artery was 
deﬁ  ned as the portion 10 mm above the tip of the 
ﬂ  ow divider. IMT was deﬁ  ned as a focal or linear 
area with lumen projections  1.5 mm. All images 
with lumen projections  1.1 mm were considered 
as plaques. Ultrasonic plaque structure was 
deﬁ  ned according to the classiﬁ  cation proposed 
by Gray-Weale et al. (1988). Carotid stenosis was 
evaluated using an electronic caliper [% stenosis 
= (total vessel diameter − residual diameter)/total 
diameter × 100]. All measurements of B-scan 
images were done in real time.
DNA Sample
We obtained blood samples and genomic DNA 
with informed consent as overseen by the Ethical 
Committee of Iwate Medical University. Genomic 
DNA was prepared from white blood cells using 
a DNA extraction kit (WAKO Inc., Tokyo, 
Japan).
Selection of Candidate Genes 
and SNPs
We selected 8 SNPs from candidate genes that may 
be related to atherosclerosis, including genes 
involved in the renin-angiotensin system, cytokine, 
growth factors, and the coagulation-ﬁ  brinolysis 
system (Table 1).
We designed polymerase chain reaction (PCR) 
primers to amplify the regions surrounding SNPs 
using computer software. Gene nomenclature and 
symbols were based on The Genome Database 
(GDB; http://www.gdb.org/). SNPs were identiﬁ  ed 
using the Online Mendelian Inheritance in Man 
database (OMIM; http://www.ncbi.nlm.nih.gov/
Omim/), the Human Gene Mutation Database 
(HGMD; http://archive.uwcm.ac.uk/uwcm/mg/
hgmd/search.html), and the IMS-JST Japanese 
SNPs Database (http://snp.ims.u-tokyo.ac.jp/
index_ja.html). We selected SNPs that were 
reported frequently in the Japanese population in 
cases where several polymorphisms were encoun-
tered. We obtained Genomic DNA sequences 
around SNP sites from GenBank (http://www.ncbi.
nlm.nih.gov/).
Oligonucleotide-Based DNA Array
The principle of the procedure is an oligonucleotide-
based DNA array. Ampliﬁ  ed biotinylated DNA 
material is hybridized with speciﬁ  c oligonucleotide 
probes immobilized as parallel lines on membrane-
based strips. After hybridization, streptavidin 
labeled with alkaline phosphatase is added, and 
binds to any hybrid formed. After washing, incuba-
tion with BCIP/NBT chromogen results in a purple/
brown precipitate (Fig. 1).
The details of the procedure are as follows. A 
volume (10 µL) of denaturation solution and 45 
µL of ampliﬁ  ed product were added into the upper 
corner of each well, mixed, and kept at room tem-
perature for 5 minutes. Then the reaction mixture 
was added to 1 ml of warm (45 ºC) hybridization 
solution, and mixed gently. The strip was placed 
into a trough immediately, and incubated at 45 ºC 
on a shaker for 30 minutes (the following incuba-
tions were done on the shaker). After the reaction, 
1 mL of warm stringent wash solution (SW) 65
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Substance 
(NBT/BCIP) Fluorescence color development
biotin
Streptavidin
alkaline phosphatase 
Amplified DNA
Strip which oligonucleotide connected
Substance 
(NBT/BCIP) Fluorescence color development
biotin
Streptavidin
alkaline phosphatase 
Amplified DNA
Strip which oligonucleotide connected
Figure 1. Schema for genotyping candidate SNPs (analyzed by LiPA) by reverse hybridization.  Ampliﬁ  ed biotinylated DNA material is hybrid-
ized with speciﬁ  c oligonucleotide probes immobilized as parallel lines on membrane-based strips. After hybridization, streptavidin labeled 
with alkaline phosphatase is added, and binds to any hybrid formed. After washing, incubation with nitro blue tetrazolium (NBT)/5-bromo-4-
chloro-3-indolyl phosphate (p-toluidine salt) (BCIP) results in formation of a purple/brown precipitate.b.
Table 1. Eight candidate SNPs and primer design.
Gene  Gene symbol  Polymorphism  Primer 1  Primer 2
R-A System      
Angiotensin I  AGT  803  C T:  gctgctccc  C:  ctgacgggag
     tgatggga    ccagtgtgga 
Angiotensin AGTR1  1166  A C C:  aaatgagcc  T:  aaatgagca
receptor 1      ttagctac  ttagctac
NOS3   NOS3  894 G T G:  gatgag  T:  cagatgatc
     cccccag    ccccaga 
Cytokine      
Chemokine CCR2  190  G A G:  tggtcgt  A:  atgctggt
receptor 2      cctcatctt   catcctca 
Growth factor      
Hepatocyte HGF  1652  C T C:  gaggac  T:  gaggattga
growth factor    (intron1)  tgaaaaaagc   aaaaagc 
Transgelin SM22-1  A G (promoter  A: gctcacca  G: gctcacca
   region)  agccacagg    ggccacag 
Coagulation-ﬁ  brinolysis        
5, 10-Methylenetetra  MTHFR  677 C T C:  gcggg  T:  cgggag 
hydrofolate     agtcgattt    ccgatttcat
Plasminogen activator  PAI1  –1965 del G  4G: acacgtg  5G: acacgtgg 
inhibitor 1      gggagtca  gggagtca 66
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was added to each well, and it was rinsed for 
10–20 seconds. A volume (1 mL) of SW was added 
to each well and incubated at 45 ºC for 10 minutes. 
Each strip was washed twice for 1 minute using 
1 mL of rinse solution. A volume (1 mL) of con-
jugate solution was added to each well and incu-
bated at room temperature for 30 minutes. Each 
strip was washed twice for 1 minute using 1 mL 
of rinse solution, and then washed using 1 mL of 
substrate buffer for 1 minute. Substrate solution 
(1 mL) was added to each well and kept at room 
temperature for 30 minutes. The color development 
was stopped by washing the strip in 1 mL of dis-
tilled water while agitating the tray on the shaker 
for 10 minutes. The strip was removed from the 
well and dried completely to detect genotypes from 
the coloring pattern.
Genotyping of Candidate SNPs
Genotyping of candidate SNPs was performed 
using an oligonucleotide-based DNA array (LiPA). 
Representative genotypes are presented in Figure 2. 
To evaluate the accuracy of the assay procedure, 
we determined the sequence of 8 SNPs in all 
patients by the ﬂ  uorescent dye-terminator cycle 
method using an autosequencer (model 377XL, 
Applied Biosystems, Foster City, CA) and the 
primers that were used for PCR ampliﬁ  cations.
Statistical Analysis
Data were also compiled according to the allele 
frequency and genotype. Statistical analyses 
involving odds ratios required calculation of the 
observed frequency of alleles and genotypes 
(dominant and recessive) in each group. Intergroup 
differences were tested by Fisher’s exact test. For 
all statistical analyses, p   0.05 was considered 
signiﬁ  cant. Multiple logistic regression tests, with 
the stepwise method, were carried out to determine 
the conditions influencing the progression of 
hypertension, dyslipidemia, diabetes, overweight, 
alleles and genotypes were considered as indepen-
dent variables. We used SPSS (SPSS Inc., Tokyo, 
Japan) for multiple logistic analysis.
Results
At the end of enrolment, 47 age-matched healthy 
controls and 46 consecutive patients were studied. 
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Figure 2. Representative genotyping of 8 SNPs analyzed using oligonucleotide-based DNA array (LiPA).67
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Their general data and risk factors are given 
in Table 2.
The risk factors assessed (male, overweight, and 
hypertension) were not different between these two 
groups, except for hypertension and diabetes 
mellitus (DM), which had a lower prevalence in 
patients.
In 8 SNPs, there was complete agreement in 
sequence between the oligonucleotide-based DNA 
array (LiPA) and the ﬂ  uorescent dye-terminator 
cycle method. A representative oligonucleotide-
based DNA array is presented in Figure 2.
The allele frequency of PAI-1 –1965 delG (OR: 
0.3, 95% CI, 0.2–0.6) and 5,10-methylenetetrahy-
drofolate reductase (MTHFR) (OR 1.3, 95% CI, 
1.0–1.5) were signiﬁ  cantly different between con-
trols and cases with ICA stenosis by Fisher’s exact 
test. Stepwise multiple regression analysis was 
carried out to determine the association of known 
risk factors with ICA stenosis. The results are 
summarized in Table 3. Multiple logistic analysis 
revealed that DM, SNPs in PAI-1 –1965 delG and 
MTHFR were an independent risk for ICA stenosis, 
as shown in Table 4.
Discussion
In the present study, we demonstrated that SNPs 
including coagulation-fibrinolysis analyzed 
oligonucleotide-based custom DNA Array as well 
as DM was relevant at risk in patients with ICA 
Stenosis.
Recent novel DNA sequencing approaches offer 
the prospect of identifying increasing numbers of 
SNPs at a reduced cost by high-throughput SNP 
discovery mature. Several promising methods for 
semi-automated or fully automated discovery or 
scoring of SNPs have been developed, including 
the Taqman approach, DNA chips, and the Invader 
Table 2. Patient background.
 CONTROL  ICA  stenosis
Number   47  46
AGE 63  ± 10  67 ± 8
BMI 23  ± 2.4  23 ± 3.5
SBP 136  ± 15  141 ± 17
DBP 79  ± 8  79 ± 11
TC 202  ± 25  190 ± 36
TG 135  ± 67  154 ± 114
HDL 51  ± 14  53 ± 19
HBA1C 5.2  ± 0.5  5.6 ± 0.8
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that two genetic variants, SNP rs2227631 and the 
PAI-1 –1965 delG (4G/5G polymorphism), were 
strongly associated (p   0.0001) with PAI-1 
levels among participants in the Framingham 
Heart Study. Thus, we speculated that the 
decreased cell-surface ﬁ  brinolytic activity likely 
to result from the increased PAI-1 expression may 
stimulate vascular smooth muscle cell prolifera-
tion. Furthermore, Bova et al. (2000) reported that 
alanine/valine (A/V) polymorphism at codon 677 
of the MTHFR gene was associated signiﬁ  cantly 
with severe CAS. We also demonstrated an 
increased concentration of homocysteine in ala-
nine/valine polymorphism at codon 677 of the 
MTHFR gene and risk for myocardial infarction 
(Nakai et al. 2000).
Some of these gene polymorphisms, such as 
insertion/deletion (I/D) polymorphism of the 
ACE gene (Mattace-Raso et al. 2004), and 
apolipoprotein  E (APOE) (Beilby et al. 2003) have 
been reported as a disease-candidate risk for ICA 
stenosis and coronary artery disease. Topic et al. 
(2001) showed an association of the MTHFR and 
APOE gene polymorphism with cerebrovascular 
disease, suggesting a signiﬁ  cant risk for stroke in 
subjects who are homozygous for the T allele and 
for carotid stenosis in subjects having the APOE 
epsilon3/epsilon4 genotype.
Thus, genome-wide maps of SNPs might 
provide an efﬁ  cient means of identifying new 
disease-susceptibility genes. Several surveys of 
this kind have been reported (Cargill et al. 1999; 
Halushka et al. 1999; Ohnishi et al. 2000). By 
cataloging dense maps of SNPs it may be possible 
to directly test the association of each SNP in 
individuals at high risk for ICA stenosis. In the 
present study, we demonstrated the the possibility 
of clinical utility of an oligonucleotide-based 
DNA array (LiPA).
Study Limitation
Some important limitations should be recognized 
when interpreting the results of this study. First, 
the sample size was small, so that the potential 
effects of co-morbidities cannot be excluded. 
Second, more efﬁ  cient and dense SNP arrays will 
be needed to screen for inheritance-based ICA 
stenosis in populations.
In conclusion, genetic factors of coagulation-
ﬁ  brinolysis as well as diabetes mellitus (DM) were 
relevant in ICA stenosis. Oligonucleotide-based 
assay (Kwiatkowski et al. 1999; Fan et al. 2000). 
DNA chips are very expensive for routine clinical 
use for screening SNPs in patients with ICA 
stenosis. In the present study, we used an 
oligonucleotide-based DNA array (LiPA). The 
oligonucleotide-based DNA array (LiPA) analyzed 
the 8 SNPs of interest with enough accuracy as 
conﬁ  rmed by ﬂ  uorescent dye-terminator cycle 
sequencing.
Previously, we reported 39 SNPs by chip-based 
MALDI-TOF MS using the MassARRAY system 
with a high level of accuracy at multiplex assays 
(Nakai et al. 2002). In 19 Japanese patients with 
myocardial infarction whose ﬁ  rst attack occurred 
before the age of 50 years, signiﬁ  cant differences 
were observed in the –1965 delG of PAI-1 with 
respect to allelic frequency, the G A in the pro-
moter region SNP in SM22 (TAGLN) for 
dominant genotype, and in two other SNPs (C T 
in intron 1 of HGF, and –1965 delG of PAI-1) for 
recessive genotype. These surveys within candi-
date genes associated with coronary artery disease 
may prove relevant to studies of SNP-associated 
diseases in general.
In patients with 80–99% of stenosis in carotid 
artery, strokes occurred as well as contra-lateral to 
the plaque (Bock et al. 1993), and a high degree 
of stenosis was predictive of coronary events 
(Sillesen, 2002). Theoretically, the pathophysio-
logical nature of the coronary artery and internal 
carotid artery may be similar. Therefore, we tested 
8 SNPs to examine for a genetic risk factor for ICA 
stenosis. Among the 8 candidate genes, signiﬁ  cant 
disequilibrium was observed in SNP-related genes 
of the PAI-1 –1965 delG allele, and MTHFR 
among controls and patients.
PAI-1, known to inhibit ﬁ  brinolysis in the 
circulation and to be present within atherosclerotic 
vessels, may inﬂ  uence proteolysis in the arterial 
wall. Sawa et al. (1994) demonstrated that gene 
and protein expression of plasminogen activator 
inhibitor type 1 (PAI-1) was increased from 1 to 
4 weeks within the balloon injured carotid arteries. 
In addition, Kathiresan et al. (2005) demonstrated 
Table 4. Summary of multiple logistic analysis.
Risk factor  beta  p-value RR
DM 1.44  0.02  4.2
MTHFR hetero  1.45  0.01  4.4
PAI1 homo  1.67  0.01  0.269
Screening SNPs in patients with internal carotid artery stenosis
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DNA arrays have led to the expectation that 
understanding the genetic basis of ICA stenosis.
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